Comparative efficacy of saxagliptin combination therapy with acarbose, or gliclazide modified release, or metformin in drug naive patients with type 2 diabetes

被引：0
|
作者：
Chen, X. P. [1 ]
Li, H. M. [2 ]
Kuang, H. Y. [3 ]
Chen, L. [4 ]
Ma, J. H. [5 ]
Zhang, Q. [6 ]
Pan, T. R. [7 ]
He, J. [8 ]
Yang, W. Y. [1 ]
机构：
[1] China Japan Friendship Hosp, Beijing, Peoples R China
[2] China Meitan Gen Hosp, Beijing, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China
[4] Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China
[5] Nanjing Med Univ, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China
[6] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China
[7] Anhui Med Univ, Hosp 2, Hefei, Anhui, Peoples R China
[8] Tulane Univ, New Orleans, LA 70118 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
768
引用
收藏
页码：S377 / S377
页数：1
相关论文
共 50 条
  • [31] Clinical efficacy of gliclazide with modified release after myocardial infarction in patients with concomitant type 2 diabetes
    Mikhaylovska, N. S.
    ZAPOROZHYE MEDICAL JOURNAL, 2014, (02) : 8 - 12
  • [32] Comparative Efficacy of Metformin and Sulfonylurea in Monotherapy or Combination for Type 2 Diabetes
    Eltaib, Lina
    Alenzi, Shamayl M.
    ASIAN JOURNAL OF PHARMACEUTICAL RESEARCH AND HEALTH CARE, 2020, 12 (04) : 223 - 233
  • [33] Efficacy of insulin-metformin combination therapy in patients with type 2 diabetes mellitus
    Jaber, LA
    Slaughter, RL
    DIABETES, 1998, 47 : A88 - A88
  • [34] A comparative study of acarbose, vildagliptin and saxagliptin intended for better efficacy and safety on type 2 diabetes mellitus treatment
    Wang, Zhongchao
    Wang, Jing
    Hu, Jianxia
    Chen, Ying
    Dong, Bingzi
    Wang, Yangang
    LIFE SCIENCES, 2021, 274
  • [35] Efficacy and Safety of Saxagliptin in Combination With Insulin in Elderly Patients With Type 2 Diabetes
    Charbonnel, Bernard
    Barnett, Anthony H.
    Monyak, John
    Minervini, Gianmaria
    Iqbal, Nayyar
    DIABETES, 2012, 61 : A269 - A269
  • [36] Long-term combination therapy with pioglitazone plus metformin for Type 2 diabetes: a randomised, comparative study with gliclazide plus metformin.
    Maher, LJ
    Edwards, GC
    Lee, CEF
    Urquhart, R
    Herz, M
    Tan, MH
    DIABETOLOGIA, 2003, 46 : A288 - A288
  • [37] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
    Moses, Robert G.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
  • [38] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
    Du, Jin
    Liang, Li
    Fang, Hui
    Xu, Fengmei
    Li, Wei
    Shen, Liya
    Mu, Yiming
    DIABETES, 2016, 65 : A293 - A293
  • [39] Efficacy and safety of saxagliptin in drug-naive Asian patients with type 2 diabetes mellitus: a randomized controlled trial
    Pan, Chang Yu
    Yang, Wenying
    Tou, Conrad
    Gause-Nilsson, Ingrid
    Zhao, June
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 (03) : 268 - 275
  • [40] Comparative effectiveness of gliclazide modified release versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes
    Zaccardi, Francesco
    Jacquot, Emmanuelle
    Cortese, Viviana
    Tyrer, Freya
    Seidu, Samuel
    Davies, Melanie J.
    Khunti, Kamlesh
    DIABETES OBESITY & METABOLISM, 2020, 22 (12): : 2417 - 2426
12345